Bernstein says this cheap EU pharma stock is "a value trap"
Investing.com -- Bernstein lifted its price target on a European drugmaker and maintained its “Underperform” rating, warning the obesity-drug giant ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
